產(chǎn)品描述: | Smoothened Agonist (SAG) HCl是一種細胞滲透性Smoothened (Smo)激動劑,其在Shh-LIGHT2細胞中的EC50約為3 nM |
靶點: |
Smoothened(mouse cultured cell assay):3 nM(EC50);Hedgehog/Smoothened |
體外研究: |
SAG通過直接結合到Smo螺旋束調(diào)控Smo活性。 SAG以GRK2依賴的方式誘導通過Gli的Smo-依賴性信號。 SAG(1 nM)也會誘導神經(jīng)元和神經(jīng)膠質(zhì)前體細胞的增殖,而不影響新生細胞的分化模式 |
體內(nèi)研究: |
在成年大鼠海馬中,SAG (2.5 nM)腦室內(nèi)給藥顯著增加新生細胞的數(shù)量,并延長海馬細胞的存活時間。 在小鼠中,SAG (20 μg/g, i.p.)有效防止GC-誘導的新生小腦發(fā)育異常 |
細胞實驗: |
Cell lines: Shh-LIGHT2 cells Concentrations: 3 nM Incubation Time: 30 h Method: Cells were treated with various concentrations of SAG in DMEM containing 0.5% (vol/vol) bovine calf serum. |
動物實驗: |
Animal Models: 大鼠 Dosages: 2.5 nM Administration: 側(cè)腦室給藥 |
參考文獻: |
1. Chen JK, et al. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci U S A. 2002, 99(22), 14071-14076. 2. Meloni AR, et al. Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol Cell Biol. 2006, 26(20), 7550-760. 3. Bragina O, et al. Smoothened agonist augments proliferation and survival of neural cells. Neurosci Lett. 2010, 482(2), 81-85. 4. Heine VM, et al. A small-molecule smoothened agonist prevents glucocorticoid-induced neonatal cerebellar injury. Sci Transl Med. 2011, 3(105), 105ra104. |
溶解性: |
Soluble in DMSO、Ethanol、H2O |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
1.899 ml |
9.496 ml |
18.993 ml |
5 mM |
0.38 ml |
1.899 ml |
3.799 ml |
10 mM |
0.19 ml |
0.95 ml |
1.899 ml |
50 mM |
0.038 ml |
0.19 ml |
0.38 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |